Financials
- Market Capitalization 1.64 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.3
ratio cours/chiffre d'affaires
162.41
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2041 | NTLA Intellia Therapeutics, Inc. - Common Stock | 11.95 USD | -5.01% | -3.32% | +2.49% | -12.90% | 1.67 B USD | ||
| 2046 | BHVN Biohaven Ltd. Common Shares | 11.19 USD | -5.17% | -7.21% | -11.19% | -33.95% | 1.69 B USD | ||
| 2052 | NUVB Nuvation Bio Inc. Class A Common Stock | 4.75 USD | -3.06% | -1.04% | -19.49% | +30.14% | 1.67 B USD | ||
| 2072 | GPCR Structure Therapeutics Inc - American Depositary Shares | 22.45 USD | -6.11% | -17.13% | -42.32% | -16.04% | 1.60 B USD |